Pharma companies turn to AI to speed up drug development, but hit hurdles
When Genentech licensed experimental drug vixarelimab from Kiniksa Pharmaceuticals, its scientists thought they had a future lung medicine in their hands. Artificial intelligence came up with another plan. It was…
With the spurt in pharma R&D, there will be a growing need for contract manufacturers: Sandeep Jain, Akums
Shahid Akhter, editor, ETHealthworld, spoke to Sandeep Jain, Joint M.D, Akums Drugs & Pharmaceutical, to know more about the challenges and opportunities associated with contract manufacturing of drugs. Contract manufacturing in the pharma…
